212 related articles for article (PubMed ID: 34312290)
1. Heterogeneity and Cancer-Related Features in Lymphangioleiomyomatosis Cells and Tissue.
Espín R; Baiges A; Blommaert E; Herranz C; Roman A; Saez B; Ancochea J; Valenzuela C; Ussetti P; Laporta R; Rodríguez-Portal JA; van Moorsel CHM; van der Vis JJ; Quanjel MJR; Villar-Piqué A; Diaz-Lucena D; Llorens F; Casanova Á; Molina-Molina M; Plass M; Mateo F; Moss J; Pujana MA
Mol Cancer Res; 2021 Nov; 19(11):1840-1853. PubMed ID: 34312290
[TBL] [Abstract][Full Text] [Related]
2. Single-Cell Transcriptomic Analysis Identifies a Unique Pulmonary Lymphangioleiomyomatosis Cell.
Guo M; Yu JJ; Perl AK; Wikenheiser-Brokamp KA; Riccetti M; Zhang EY; Sudha P; Adam M; Potter A; Kopras EJ; Giannikou K; Potter SS; Sherman S; Hammes SR; Kwiatkowski DJ; Whitsett JA; McCormack FX; Xu Y
Am J Respir Crit Care Med; 2020 Nov; 202(10):1373-1387. PubMed ID: 32603599
[No Abstract] [Full Text] [Related]
3. Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness.
Ruiz de Garibay G; Herranz C; Llorente A; Boni J; Serra-Musach J; Mateo F; Aguilar H; Gómez-Baldó L; Petit A; Vidal A; Climent F; Hernández-Losa J; Cordero Á; González-Suárez E; Sánchez-Mut JV; Esteller M; Llatjós R; Varela M; López JI; García N; Extremera AI; Gumà A; Ortega R; Plà MJ; Fernández A; Pernas S; Falo C; Morilla I; Campos M; Gil M; Román A; Molina-Molina M; Ussetti P; Laporta R; Valenzuela C; Ancochea J; Xaubet A; Casanova Á; Pujana MA
PLoS One; 2015; 10(7):e0132546. PubMed ID: 26167915
[TBL] [Abstract][Full Text] [Related]
4. Lymphangioleiomyomatosis: A Monogenic Model of Malignancy.
Krymskaya VP; McCormack FX
Annu Rev Med; 2017 Jan; 68():69-83. PubMed ID: 28099079
[TBL] [Abstract][Full Text] [Related]
5. Connectivity Map Analysis of a Single-Cell RNA-Sequencing -Derived Transcriptional Signature of mTOR Signaling.
Al Mahi N; Zhang EY; Sherman S; Yu JJ; Medvedovic M
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922083
[TBL] [Abstract][Full Text] [Related]
6. Lymphangioleiomyomatosis (LAM) Cell Atlas.
Du Y; Guo M; Wu Y; Wagner A; Perl AK; Wikenheiser-Brokamp K; Yu J; Gupta N; Kopras E; Krymskaya V; Obraztsova K; Tang Y; Kwiatkowski D; Henske EP; McCormack F; Xu Y
Thorax; 2023 Jan; 78(1):85-87. PubMed ID: 36599466
[TBL] [Abstract][Full Text] [Related]
7. Mast-Cell Tryptase Release Contributes to Disease Progression in Lymphangioleiomyomatosis.
Babaei-Jadidi R; Dongre A; Miller S; Castellanos Uribe M; Stewart ID; Thompson ZM; Nateri AS; Bradding P; May ST; Clements D; Johnson SR
Am J Respir Crit Care Med; 2021 Aug; 204(4):431-444. PubMed ID: 33882264
[No Abstract] [Full Text] [Related]
8. The Lymphangioleiomyomatosis Lung Cell and Its Human Cell Models.
Steagall WK; Pacheco-Rodriguez G; Darling TN; Torre O; Harari S; Moss J
Am J Respir Cell Mol Biol; 2018 Jun; 58(6):678-683. PubMed ID: 29406787
[TBL] [Abstract][Full Text] [Related]
9. Isolation of individual cellular components from lung tissues of patients with lymphangioleiomyomatosis.
Ando K; Fujino N; Mitani K; Ota C; Okada Y; Kondo T; Mizobuchi T; Kurihara M; Suzuki K; Hoshika Y; Ebana H; Kobayashi E; Takahashi K; Kubo H; Seyama K
Am J Physiol Lung Cell Mol Physiol; 2016 May; 310(10):L899-908. PubMed ID: 27016587
[TBL] [Abstract][Full Text] [Related]
10. In pulmonary lymphangioleiomyomatosis expression of progesterone receptor is frequently higher than that of estrogen receptor.
Gao L; Yue MM; Davis J; Hyjek E; Schuger L
Virchows Arch; 2014 Apr; 464(4):495-503. PubMed ID: 24570392
[TBL] [Abstract][Full Text] [Related]
11. Evolution of lung pathology in lymphangioleiomyomatosis: associations with disease course and treatment response.
Miller S; Stewart ID; Clements D; Soomro I; Babaei-Jadidi R; Johnson SR
J Pathol Clin Res; 2020 Jul; 6(3):215-226. PubMed ID: 32352655
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical evaluation of pulmonary lymphangioleiomyomatosis.
Grzegorek I; Lenze D; Chabowski M; Janczak D; Szolkowska M; Langfort R; Szuba A; Dziegiel P
Anticancer Res; 2015 Jun; 35(6):3353-60. PubMed ID: 26026095
[TBL] [Abstract][Full Text] [Related]
13. Bronchial involvement in advanced stage lymphangioleiomyomatosis: histopathologic and molecular analyses.
Hayashi T; Kumasaka T; Mitani K; Okada Y; Kondo T; Date H; Chen F; Oto T; Miyoshi S; Shiraishi T; Iwasaki A; Hara K; Saito T; Ando K; Kobayashi E; Gunji-Niitsu Y; Kunogi M; Takahashi K; Yao T; Seyama K
Hum Pathol; 2016 Apr; 50():34-42. PubMed ID: 26997436
[TBL] [Abstract][Full Text] [Related]
14. Circulating Lymphangioleiomyomatosis Tumor Cells With Loss of Heterozygosity in the TSC2 Gene Show Increased Aldehyde Dehydrogenase Activity.
Pacheco-Rodríguez G; Steagall WK; Samsel L; Dagur PK; McCoy JP; Tunc I; Pirooznia M; Wang JA; Darling TN; Moss J
Chest; 2019 Aug; 156(2):298-307. PubMed ID: 31034819
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta 1 and extracellular matrix-associated fibronectin expression in pulmonary lymphangioleiomyomatosis.
Evans SE; Colby TV; Ryu JH; Limper AH
Chest; 2004 Mar; 125(3):1063-70. PubMed ID: 15006970
[TBL] [Abstract][Full Text] [Related]
16. Tissue-specific renin-angiotensin system in pulmonary lymphangioleiomyomatosis.
Valencia JC; Pacheco-Rodriguez G; Carmona AK; Xavier J; Bruneval P; Riemenschneider WK; Ikeda Y; Yu ZX; Ferrans VJ; Moss J
Am J Respir Cell Mol Biol; 2006 Jul; 35(1):40-7. PubMed ID: 16474096
[TBL] [Abstract][Full Text] [Related]
17. Immunohistological features related to functional impairment in lymphangioleiomyomatosis.
Nascimento ECTD; Baldi BG; Mariani AW; Annoni R; Kairalla RA; Pimenta SP; da Silva LFF; Carvalho CRR; Dolhnikoff M
Respir Res; 2018 May; 19(1):83. PubMed ID: 29739412
[TBL] [Abstract][Full Text] [Related]
18. Osteoprotegerin contributes to the metastatic potential of cells with a dysfunctional TSC2 tumor-suppressor gene.
Steagall WK; Pacheco-Rodriguez G; Glasgow CG; Ikeda Y; Lin JP; Zheng G; Moss J
Am J Pathol; 2013 Sep; 183(3):938-50. PubMed ID: 23867796
[TBL] [Abstract][Full Text] [Related]
19. Clinical and molecular insights into lymphangioleiomyomatosis.
Steagall WK; Taveira-DaSilva AM; Moss J
Sarcoidosis Vasc Diffuse Lung Dis; 2005 Dec; 22 Suppl 1():S49-66. PubMed ID: 16457017
[TBL] [Abstract][Full Text] [Related]
20. Characterization of cells cultured from chylous effusion from a patient with sporadic lymphangioleiomyomatosis.
Grzegorek I; Zuba-Surma E; Chabowski M; Janczak D; Szuba A; Dziegiel P
Anticancer Res; 2015 Jun; 35(6):3341-51. PubMed ID: 26026094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
